Alkermes plc. Operating Leases, Future Minimum Payments, Due in Five Years
Alkermes plc. (ALKS) had Operating Leases, Future Minimum Payments, Due in Five Years of $2.39 million as of 2018-12-31, per its 10-K filed 2020-02-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2020-02-13
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $2.39M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $1.20M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $1.72M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $3.19M.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2018-12-31 | $2.39M 10-K · filed 2020-02-13 |
| 2017-12-31 | $1.20M 10-K · filed 2018-02-16 |
| 2016-12-31 | $1.72M 10-K · filed 2017-02-17 |
| 2015-12-31 | $3.19M 10-K · filed 2016-02-25 |
| 2014-12-31 | $5.42M 10-K · filed 2015-02-24 |
| 2013-12-31 | $4.51M 10-KT · filed 2014-02-27 |
| 2013-03-31 | $3.65M 10-K · filed 2013-05-23 |
| 2012-03-31 | $3.47M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |